Advances In Vitiligo Treatment
March 2026
in “
International Journal of Dermatology Venereology and Leprosy Sciences
”
Studysummary This study describes vitiligo as an autoimmune disease marked by depigmented skin and mucosal patches, and reviews its complex pathogenesis and diagnostic features. Treatment aims for disease control and repigmentation through various topical and systemic therapies, phototherapy, and surgical options, emphasizing personalized, multimodal approaches.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
Vitiligo is an autoimmune disease characterized by depigmented skin patches, with its pathogenesis involving genetic factors, oxidative stress, and immune responses. The disease is diagnosed through clinical indicators and supported by various diagnostic tools. Treatment focuses on stopping disease progression and promoting repigmentation, using topical therapies like corticosteroids and JAK inhibitors, systemic options such as methotrexate and cyclosporine, and adjunctive methods including phototherapy and surgical grafting. An individualized, multimodal approach is crucial for effective repigmentation and improving patient quality of life.
